Cancer, Advanced Terminated Phase 1 / 2 Trials for Paclitaxel (DB01229)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

DBCOND0041606 (Cancer, Advanced)Terminated1 / 2 IdentifierTitlePurposeDrugs
NCT02711137Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesTreatment
NCT02331251Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)Treatment